(Q44316232)

1 December 2017

In vivo evaluation of guargum-based colon-targeted oral drug delivery systems of celecoxib in human volunteers (English)

1 reference

1 December 2017

1 reference

Y S R Krishnaiah

1

1 reference

1 December 2017

V Satyanarayana

2

1 reference

1 December 2017

B Dinesh Kumar

3

1 reference

1 December 2017

R S Karthikeyan

4

1 reference

1 December 2017

P Bhaskar

5

1 reference

1 December 2017

1 October 2002

1 reference

European Journal of Drug Metabolism and Pharmacokinetics

1 December 2017

1 reference

1 December 2017

27

1 reference

1 December 2017

4

1 reference

1 December 2017

273-280

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03192338

1 December 2017

0 references

cites work

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1007%2FBF03192338

Aspirin-like molecules that covalently inactivate cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03192338

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03192338

Studies on the development of colon-targeted delivery systems for celecoxib in the prevention of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03192338

Development of colon targeted drug delivery systems for mebendazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03192338

In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03192338

Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

21 January 2018

1 reference

12 December 2020

AUC-RPP: BASIC computer program for compartment model independent pharmacokinetic analysis

1 reference

12 December 2020

Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

1 reference

12 December 2020

Chemoprevention of colorectal cancer

1 reference

12 December 2020

In vitro evaluation of guar gum as a carrier for colon-specific drug delivery

1 reference

12 December 2020

Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats.

1 reference

12 December 2020

Design and in vitro evaluation of oral colon targeted drug delivery systems for tinidazole

1 reference

12 December 2020

Studies on the development of oral colon targeted drug delivery systems for metronidazole in the treatment of amoebiasis

1 reference

12 December 2020

Studies of guar gum compression-coated 5-aminosalicylic acid tablets for colon-specific drug delivery

1 reference

12 December 2020

Gamma scintigraphic studies on guar gum matrix tablets for colonic drug delivery in healthy human volunteers

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03192338

1 reference

1 December 2017

1 reference